Correlation Between INTEL CDR and Medicenna Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both INTEL CDR and Medicenna Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining INTEL CDR and Medicenna Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between INTEL CDR and Medicenna Therapeutics Corp, you can compare the effects of market volatilities on INTEL CDR and Medicenna Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in INTEL CDR with a short position of Medicenna Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of INTEL CDR and Medicenna Therapeutics.

Diversification Opportunities for INTEL CDR and Medicenna Therapeutics

-0.39
  Correlation Coefficient

Very good diversification

The 3 months correlation between INTEL and Medicenna is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding INTEL CDR and Medicenna Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medicenna Therapeutics and INTEL CDR is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on INTEL CDR are associated (or correlated) with Medicenna Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medicenna Therapeutics has no effect on the direction of INTEL CDR i.e., INTEL CDR and Medicenna Therapeutics go up and down completely randomly.

Pair Corralation between INTEL CDR and Medicenna Therapeutics

Assuming the 90 days trading horizon INTEL CDR is expected to generate 0.47 times more return on investment than Medicenna Therapeutics. However, INTEL CDR is 2.15 times less risky than Medicenna Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Medicenna Therapeutics Corp is currently generating about 0.0 per unit of risk. If you would invest  1,380  in INTEL CDR on August 29, 2024 and sell it today you would earn a total of  34.00  from holding INTEL CDR or generate 2.46% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

INTEL CDR  vs.  Medicenna Therapeutics Corp

 Performance 
       Timeline  
INTEL CDR 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in INTEL CDR are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating technical and fundamental indicators, INTEL CDR exhibited solid returns over the last few months and may actually be approaching a breakup point.
Medicenna Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medicenna Therapeutics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

INTEL CDR and Medicenna Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with INTEL CDR and Medicenna Therapeutics

The main advantage of trading using opposite INTEL CDR and Medicenna Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if INTEL CDR position performs unexpectedly, Medicenna Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medicenna Therapeutics will offset losses from the drop in Medicenna Therapeutics' long position.
The idea behind INTEL CDR and Medicenna Therapeutics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk